Cynthia Flanders - 13 Jan 2026 Form 4 Insider Report for ARGAN INC (AGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jan 2026, 17:00:11 UTC
Prior SEC filing
17 Dec 2025
Next SEC filing
23 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cynthia A. Flanders

Key filing fact

Cynthia Flanders filed Form 4 for ARGAN INC (AGX) on 14 Jan 2026.

Key facts

  • This page summarizes Cynthia Flanders's Form 4 filing for ARGAN INC (AGX).
  • 8 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 14 Jan 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 17 Dec 2025.
  • Current net transaction value: -$161,302.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001463638 Primary reporting owner

Flanders Cynthia

Relationship
Director
Address
10006 WILDWOOD ROAD, KENSINGTON
Signature
/s/ Cynthia A. Flanders
Signature date
14 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGX transaction

Common Stock

Options Exercise

Transaction value
$349,827
Shares
+8,713
Change %
+46%
Price
$40.15
Shares after
27,841
Date
13 Jan 2026
Ownership
Direct
Footnotes
F1
AGX transaction

Common Stock

Options Exercise

Transaction value
$390,430
Shares
+8,534
Change %
+31%
Price
$45.75
Shares after
36,375
Date
13 Jan 2026
Ownership
Direct
Footnotes
F2
AGX transaction

Common Stock

Options Exercise

Transaction value
$163,558
Shares
+4,405
Change %
+12%
Price
$37.13
Shares after
40,780
Date
13 Jan 2026
Ownership
Direct
Footnotes
F3
AGX transaction

Common Stock

Options Exercise

Transaction value
$158,132
Shares
+4,427
Change %
+11%
Price
$35.72
Shares after
45,207
Date
13 Jan 2026
Ownership
Direct
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGX transaction Derivative

Option to Purchase Common Stock

Options Exercise

Transaction value
$401,500
Shares
-10,000
Change %
-32%
Price
$40.15
Shares after
21,500
Date
13 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$40.15
Footnotes
F1
AGX transaction Derivative

Option to Purchase Common Stock

Options Exercise

Transaction value
$457,500
Shares
-10,000
Change %
-47%
Price
$45.75
Shares after
11,500
Date
13 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$45.75
Footnotes
F2
AGX transaction Derivative

Option to Purchase Common Stock

Options Exercise

Transaction value
$185,650
Shares
-5,000
Change %
-43%
Price
$37.13
Shares after
6,500
Date
13 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$37.13
Footnotes
F3
AGX transaction Derivative

Option to Purchase Common Stock

Options Exercise

Transaction value
$178,600
Shares
-5,000
Change %
-77%
Price
$35.72
Shares after
1,500
Date
13 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$35.72
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method.

Footnote F2

On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.

Footnote F3

On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.

Footnote F4

On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .